Program: RRPV

Solicitation Number: RPP-24-03-Treatment

Customer: BARDA

Release Date: 02/21/2024

Submission Deadline: 05/13/2024 1PM Eastern

Description: Requesting project proposals from product developers for the advanced clinical development and assessment of Next-Generation Therapeutics for COVID-19. BARDA has previously identified a capability gap for therapeutics that provide protection through pre-exposure prophylaxis (PrEP) and treatment against new SARS-CoV-2 variants. The purpose of this project is to partner with developers and other organizations to advance the clinical development of Next-Generation Therapeutics for COVID-19, specifically treatment.

active_solicitations

solicitation_program: RRPV

solicitation_number: RPP-24-03-Treatment

solicitation_customer: BARDA

solicitation_release_date: 02/21/2024

solicitation_submission_deadline: 05/13/2024 1PM Eastern

solicitation_description: Requesting project proposals from product developers for the advanced clinical development and assessment of Next-Generation Therapeutics for COVID-19. BARDA has previously identified a capability gap for therapeutics that provide protection through pre-exposure prophylaxis (PrEP) and treatment against new SARS-CoV-2 variants. The purpose of this project is to partner with developers and other organizations to advance the clinical development of Next-Generation Therapeutics for COVID-19, specifically treatment.

solicitation_url: https://www.rrpv.org/opportunities/

Our Collaborations